VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N902. A total of 5 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | -46.4% | 13,400 | +41.1% | 0.00% | – |
| Q2 2023 | $233 | -79.6% | 9,500 | -80.6% | 0.00% | -100.0% |
| Q1 2023 | $1,140 | +456.1% | 49,000 | +504.9% | 0.00% | – |
| Q4 2022 | $205 | -99.9% | 8,100 | -32.5% | 0.00% | – |
| Q3 2022 | $231,000 | -69.6% | 12,000 | -59.7% | 0.00% | -100.0% |
| Q2 2022 | $759,000 | +174.0% | 29,800 | +175.9% | 0.00% | – |
| Q1 2022 | $277,000 | -84.1% | 10,800 | -74.1% | 0.00% | -100.0% |
| Q4 2021 | $1,745,000 | +977.2% | 41,700 | +1019.8% | 0.00% | – |
| Q3 2021 | $162,000 | -6.9% | 3,724 | +0.8% | 0.00% | – |
| Q2 2021 | $174,000 | -65.3% | 3,696 | +1006.6% | 0.00% | -100.0% |
| Q1 2021 | $501,000 | – | 334 | +28.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 261 | +128.9% | 0.00% | -100.0% |
| Q3 2020 | $391,000 | -28.6% | 114 | -14.9% | 0.00% | 0.0% |
| Q2 2020 | $548,000 | +402.8% | 134 | +318.8% | 0.00% | – |
| Q1 2020 | $109,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 50,500 | $1,175,135 | 0.00% |
| SIMPLEX TRADING, LLC | 49,000 | $1,140 | 0.00% |
| JPMORGAN CHASE & CO | 33,000 | $768,000 | 0.00% |
| JANE STREET GROUP, LLC | 48,900 | $1,137,903 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |